These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8881429)

  • 1. The Guillain-Barré syndrome; pathogenesis and treatment.
    Van Der Meché FG
    Rev Neurol (Paris); 1996 May; 152(5):355-8. PubMed ID: 8881429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immune globulin in the Guillain-Barré syndrome.
    van der Meché FG
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):43-7. PubMed ID: 8033434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group.
    Ann Neurol; 1994 Jun; 35(6):749-52. PubMed ID: 8210234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
    Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
    Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The place of high dose immunoglobulins in the treatment of Guillain-Barré patients based upon the dutch trial.
    van der Meché FG
    Wien Klin Wochenschr Suppl; 1991; 190():17-8. PubMed ID: 1771902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside.
    Yuki N; Ang CW; Koga M; Jacobs BC; van Doorn PA; Hirata K; van der Meché FG
    Ann Neurol; 2000 Mar; 47(3):314-21. PubMed ID: 10716250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.
    van der Meché FG; Schmitz PI
    N Engl J Med; 1992 Apr; 326(17):1123-9. PubMed ID: 1552913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Hadden RD; Cornblath DR; Hughes RA; Zielasek J; Hartung HP; Toyka KV; Swan AV
    Ann Neurol; 1998 Nov; 44(5):780-8. PubMed ID: 9818934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome: multifactorial mechanisms versus defined subgroups.
    van der Meché FG; Visser LH; Jacobs BC; Endtz HP; Meulstee J; van Doorn PA
    J Infect Dis; 1997 Dec; 176 Suppl 2():S99-102. PubMed ID: 9396690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part II.
    Hartung HP; Pollard JD; Harvey GK; Toyka KV
    Muscle Nerve; 1995 Feb; 18(2):154-64. PubMed ID: 7823973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guillain-Barré syndrome and acute disseminated encephalomyelitis (ADEM)].
    Hamaguchi K
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1301-7. PubMed ID: 9128388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Guillain-Barré syndrome: diagnosis, treatment and prognosis.
    van der Meché FG
    Acta Neurol Belg; 1994; 94(2):124-7. PubMed ID: 8036879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of Guillain-Barré syndrome].
    Zagar M
    Lijec Vjesn; 1995; 117(9-10):246-9. PubMed ID: 8643018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guillain-Barré syndrome: clinical features, immune mechanisms, and therapies].
    Nomura K
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1367-9. PubMed ID: 9128414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical variants of Guillain-Barre syndrome: some aspects of differential diagnosis.
    Dididze MN
    Georgian Med News; 2009 Jan; (166):48-51. PubMed ID: 19202218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Guillain-Barré syndrome and CIDP.
    van Doorn PA
    J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.
    van der Meché FG; van Doorn PA
    Ann Neurol; 1995 May; 37 Suppl 1():S14-31. PubMed ID: 8968214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guillain-Barre syndrome: etiology and pathogenesis].
    Avila-Funes JA; Mariona-Montero VA; Melano-Carranza E
    Rev Invest Clin; 2002; 54(4):357-63. PubMed ID: 12415961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.